Nihon Kohden Share Holder Equity 2015-2024 | NHNKY
Nihon Kohden share holder equity from 2015 to 2024. Share holder equity can be defined as the sum of preferred and common equity items
| Nihon Kohden Annual Share Holder Equity (Millions of US $) |
|
|---|---|
| 2024 | $1,249 |
| 2023 | $1,240 |
| 2022 | $1,392 |
| 2021 | $1,306 |
| 2020 | $1,120 |
| 2019 | $1,045 |
| 2018 | $984 |
| 2017 | $926 |
| 2016 | $867 |
| 2015 | $826 |
| 2014 | $860 |
| Nihon Kohden Quarterly Share Holder Equity (Millions of US $) |
|
|---|---|
| 2024-06-30 | $1,147 |
| 2023-06-30 | $1,238 |
| 2022-06-30 | $1,205 |
| 2021-06-30 | $1,270 |
| 2020-06-30 | $1,131 |
| 2019-06-30 | $1,037 |
| 2018-06-30 | $994 |
| 2017-06-30 | $920 |
| 2016-06-30 | $872 |
| 2015-06-30 | $800 |
| 2014-06-30 | $851 |
| 2014-03-31 | $860 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | MED INSTRUMENTS | $2.004B | $1.538B |
| Nihon Kohden Corporation is a Japan-based company engaged in the research, development, manufacture and sale of medical electronic equipment, as well as the provision of maintenance and repair services. The Company offers electroencephalograph, electromyography, evoked potential testing equipment, electrocardiographs, cardiac catheterization equipment, diagnostic information systems and related consumables (paper, electrodes, catheters and others), biological information monitors, clinical information systems, artificial respiration, artificial ear, hemocytometer, ultrasonic diagnostic equipment, research equipment and transformers, among others. The Company is also engaged in the sales promotion for its products, as well as the general affair-related and manpower dispatching businesses. | |||